Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Salvianolic acid for plaque stability and angiogenesis in massive cerebral infarction
ChiCTR1800015677Phase 4Recruiting
- Sponsor
- Shanxi Provincial People's Hospital
- Start
- Apr 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of danshen polyphenolic acid in brain infarction (2 arms), sponsored by Shanxi Provincial People's Hospital. Primary endpoints: MRI arterial spin labeling imaging, MRI diffusion-weighted imaging and 2 more. Started Apr 2018; status: recruiting.
02
Drugs
danshen polyphenolic acid
03
Conditions
brain infarction
Beyond the preview
Go deeper on ChiCTR1800015677.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR1800015677.